News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,566 Results
Type
Article (59993)
Company Profile (315)
Press Release (643257)
Multimedia
Podcasts (120)
Webinars (19)
Section
Business (191911)
Career Advice (2782)
Deals (34827)
Drug Delivery (128)
Drug Development (83692)
Employer Resources (163)
FDA (17519)
Job Trends (15286)
News (338905)
Policy (36181)
Tag
Academia (2866)
Academic (1)
Accelerated approval (10)
Adcomms (32)
Allergies (103)
Alliances (50009)
ALS (117)
Alzheimer's disease (1549)
Antibody-drug conjugate (ADC) (187)
Approvals (17471)
Artificial intelligence (356)
Autoimmune disease (36)
Automation (18)
Bankruptcy (358)
Best Places to Work (11782)
BIOSECURE Act (22)
Biosimilars (132)
Biotechnology (215)
Bladder cancer (100)
Brain cancer (40)
Breast cancer (377)
Cancer (3002)
Cardiovascular disease (244)
Career advice (2345)
Career pathing (34)
CAR-T (205)
CDC (40)
Cell therapy (549)
Cervical cancer (24)
Clinical research (68482)
Collaboration (1090)
Company closure (3)
Compensation (681)
Complete response letters (30)
COVID-19 (2850)
CRISPR (67)
C-suite (341)
Cystic fibrosis (118)
Data (2999)
Decentralized trials (2)
Denatured (34)
Depression (73)
Diabetes (374)
Diagnostics (6525)
Digital health (25)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (163)
Drug pricing (151)
Drug shortages (36)
Duchenne muscular dystrophy (129)
Earnings (72843)
Editorial (48)
Employer branding (21)
Employer resources (146)
Events (106040)
Executive appointments (899)
FDA (19217)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (978)
Gene editing (147)
Generative AI (30)
Gene therapy (425)
GLP-1 (915)
Government (4852)
Grass and pollen (6)
Guidances (179)
Healthcare (19471)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (182)
Immuno-oncology (10)
Indications (40)
Infectious disease (3040)
Inflammatory bowel disease (155)
Inflation Reduction Act (13)
Influenza (68)
Intellectual property (121)
Interviews (516)
IPO (16356)
IRA (55)
Job creations (3933)
Job search strategy (1940)
Kidney cancer (14)
Labor market (49)
Layoffs (576)
Leadership (26)
Legal (8656)
Liver cancer (84)
Lung cancer (425)
Lymphoma (214)
Machine learning (11)
Management (56)
Manufacturing (420)
MASH (95)
Medical device (13857)
Medtech (13862)
Mergers & acquisitions (19208)
Metabolic disorders (944)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (139)
Neuropsychiatric disorders (40)
Neuroscience (2283)
NextGen: Class of 2025 (6854)
Non-profit (4656)
Now hiring (33)
Obesity (485)
Opinion (283)
Ovarian cancer (102)
Pain (116)
Pancreatic cancer (120)
Parkinson's disease (198)
Partnered (22)
Patents (306)
Patient recruitment (163)
Peanut (53)
People (59051)
Pharmaceutical (70)
Pharmacy benefit managers (25)
Phase I (21121)
Phase II (29810)
Phase III (22767)
Pipeline (1668)
Policy (239)
Postmarket research (3043)
Preclinical (9149)
Press Release (71)
Prostate cancer (147)
Psychedelics (44)
Radiopharmaceuticals (273)
Rare diseases (514)
Real estate (5895)
Recruiting (65)
Regulatory (25355)
Reports (41)
Research institute (2553)
Resumes & cover letters (447)
Rett syndrome (10)
RNA editing (8)
RSV (56)
Schizophrenia (97)
Series A (171)
Series B (112)
Service/supplier (17)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (36)
Startups (3663)
State (1)
Stomach cancer (17)
Supply chain (82)
Tariffs (65)
The Weekly (84)
Vaccines (896)
Venture capital (57)
Weight loss (327)
Women's health (43)
Worklife (20)
Date
Today (103)
Last 7 days (344)
Last 30 days (2085)
Last 365 days (32534)
2025 (17322)
2024 (36335)
2023 (41041)
2022 (52163)
2021 (56652)
2020 (55096)
2019 (47788)
2018 (36235)
2017 (34184)
2016 (33394)
2015 (37936)
2014 (30655)
2013 (25612)
2012 (27435)
2011 (28165)
2010 (26096)
Location
Africa (948)
Alabama (69)
Alaska (7)
Arizona (219)
Arkansas (14)
Asia (42689)
Australia (7315)
California (7451)
Canada (2280)
China (710)
Colorado (317)
Connecticut (337)
Delaware (199)
Europe (98098)
Florida (1130)
Georgia (258)
Hawaii (2)
Idaho (61)
Illinois (674)
India (31)
Indiana (368)
Iowa (17)
Japan (233)
Kansas (102)
Kentucky (31)
Louisiana (17)
Maine (71)
Maryland (1051)
Massachusetts (5593)
Michigan (255)
Minnesota (446)
Mississippi (3)
Missouri (99)
Montana (32)
Nebraska (26)
Nevada (77)
New Hampshire (72)
New Jersey (2104)
New Mexico (29)
New York (2078)
North Carolina (1161)
North Dakota (9)
Northern California (3238)
Ohio (242)
Oklahoma (17)
Oregon (39)
Pennsylvania (1569)
Puerto Rico (18)
Rhode Island (35)
South America (1313)
South Carolina (35)
South Dakota (1)
Southern California (2791)
Tennessee (126)
Texas (1115)
United States (27832)
Utah (215)
Virginia (193)
Washington D.C. (72)
Washington State (632)
West Virginia (4)
Wisconsin (79)
703,566 Results for "esteve s a laboratorios del dr esteve s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ESTEVE to acquire medicine to treat medullary thyroid cancer
June 30, 2025
·
3 min read
Pharm Country
ESTEVE Launches INBRIJA® in Spain
Acorda Therapeutics, Inc. announced that Esteve Pharmaceuticals, S.A. has launched INBRIJA 33 mg in Spain.
March 7, 2023
·
5 min read
Press Releases
Avidity Biosciences Announces the Accelerated Approval Regulatory Pathway in the U.S. is Open for Del-Brax and Initiates the Global, Confirmatory Phase 3 FORWARD™ Study in FSHD
June 9, 2025
·
13 min read
Bladder cancer
UroGen’s Bladder Cancer Drug Wins FDA Approval Over Adcomm’s Objections
The FDA’s Oncologic Drugs Advisory Committee narrowly voted against the approval of Zusduri, citing the lack of a completely randomized study to back up the application.
June 13, 2025
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Lilly Gets FDA Label Update for Alzheimer’s Drug To Mitigate Safety Concerns
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of the monoclonal antibody drug class that has led to several deaths.
July 9, 2025
·
2 min read
·
Annalee Armstrong
Women’s Health
Organon’s Endometriosis Drug Discontinued After Failing To Improve Pain
The women’s health focused company acquired the drug for up to $954 million in 2021 through the acquisition of Forendo Pharma.
July 2, 2025
·
1 min read
·
Annalee Armstrong
Podcast
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
President Donald Trump unwrapped a massive drug pricing policy as CMS prepares for the next round of Medicare drug price negotiations; Vinay Prasad to take the helm at the FDA’s Center for Biologics Evaluation and Research; Bayer cuts 2,000 more employees; Eli Lilly’s Zepbound scores again; and the Galapagos story turns again.
May 14, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
June 5, 2025
·
12 min read
Press Releases
Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials
June 9, 2025
·
7 min read
Editorial
Rest Up, Biopharma. Trump’s Drug Pricing Policy Is Coming on Monday
With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have railed against, the industry’s tumultuous ride is far from over.
May 9, 2025
·
4 min read
·
Annalee Armstrong
1 of 70,357
Next